Rxi, UMMS Receive Funding For Research Collaboration
The Angel Fund, The ALS Therapy Alliance and Project ALS have financed a new collaboration between ALS researchers of UMMS and RXi Pharmaceuticals (Rxi). Reportedly, Robert Brown, chair
China-based Biocytogen Pharmaceuticals has entered a non-exclusive licensing agreement with Qilu Pharmaceutical for a fully human VHH antibody molecule.